Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (1-10 of 373) with videos related to

Pageof 38
Sort By:
Developmental Medicine and Child Neurology|October 11, 2021
Adults with cerebral palsy and Alzheimer disease: a missing link?Sebastiaan Engelborghs
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease DiagnosisMaria Bjerke, Sebastiaan Engelborghs
Journal of the Neurological Sciences|September 6, 2012
The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementiaSebastiaan Engelborghs, Nathalie Le Bastard
Molecular Diagnosis & Therapy|June 1, 2012
The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's diseaseSebastiaan Engelborghs, Nathalie Le Bastard
La Revue Du Praticien|September 3, 2020
[Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]Adrian Ivanoiu, Sebastiaan Engelborghs, Bernard Hanseeuw
Alzheimer'S Research & Therapy|February 24, 2021
Melatonin levels in the Alzheimer's disease continuum: a systematic reviewAmber Nous, Sebastiaan Engelborghs, Ilse Smolders
Frontiers in Pharmacology|March 3, 2020
Depressive Symptoms in the Elderly-An Early Symptom of Dementia? A Systematic ReviewWietse Wiels, Chris Baeken, Sebastiaan Engelborghs
Frontiers in Neuroscience|August 27, 2019
The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical ImplicationsHelena Gossye, Christine Van Broeckhoven, Sebastiaan Engelborghs
Biomarkers in Medicine|January 24, 2017
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panelCharisse Somers, Joery Goossens, Sebastiaan Engelborghs, et al.
Frontiers in Immunology|July 31, 2023
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic reviewJoke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Pageof 38

Showing results (1-10 of 373) with videos related to

Sort By:
Pageof 38
Developmental Medicine and Child Neurology|October 11, 2021
Adults with cerebral palsy and Alzheimer disease: a missing link?Sebastiaan Engelborghs
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease DiagnosisMaria Bjerke, Sebastiaan Engelborghs
Journal of the Neurological Sciences|September 6, 2012
The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementiaSebastiaan Engelborghs, Nathalie Le Bastard
Molecular Diagnosis & Therapy|June 1, 2012
The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's diseaseSebastiaan Engelborghs, Nathalie Le Bastard
La Revue Du Praticien|September 3, 2020
[Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]Adrian Ivanoiu, Sebastiaan Engelborghs, Bernard Hanseeuw
Alzheimer'S Research & Therapy|February 24, 2021
Melatonin levels in the Alzheimer's disease continuum: a systematic reviewAmber Nous, Sebastiaan Engelborghs, Ilse Smolders
Frontiers in Pharmacology|March 3, 2020
Depressive Symptoms in the Elderly-An Early Symptom of Dementia? A Systematic ReviewWietse Wiels, Chris Baeken, Sebastiaan Engelborghs
Frontiers in Neuroscience|August 27, 2019
The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical ImplicationsHelena Gossye, Christine Van Broeckhoven, Sebastiaan Engelborghs
Biomarkers in Medicine|January 24, 2017
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panelCharisse Somers, Joery Goossens, Sebastiaan Engelborghs, et al.
Frontiers in Immunology|July 31, 2023
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic reviewJoke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
Pageof 38